+33(0)1 42 54 60 64 | contact@welcomeurope.com
JPND supports transnational research projects that enable researchers to collaborate across borders to tackle the global challenge of neurodegenerative diseases.
Participating countries : Australia, Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Hungary, Ireland, Italy, Latvia, Luxembourg, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Turkey
Objectives
* To foster technical progress on relevant techniques that benefits for patients or for routine scientific and clinical applications;
* To encourage integration basic research and cost-effectiveness studies, where relevant;
* To favour hypotheses-driven studies and combine cutting-edge technological developments with a clear, substantial research question
Priorities
* Alzheimer’s disease and other dementias;
* Parkinson’s disease and PD‐related disorders;
* Prion diseases;
* Motor neuron diseases;
* Huntington’s disease;
* Spinocerebellar ataxia (SCA);
* Spinal muscular atrophy (SMA)
Among financed actions
* Imaging technologies: research projects that focus on the development of novel JPND call for proposals: “Novel imaging and brain stimulation methods and technologies related to Neurodegenerative Diseases” imaging technologies or on improvements to the application of existing cutting-edge imaging technologies;
* Brain stimulation techniques: the aim is to fund research that will lead to new or improved applications of both invasive and non-invasive brain stimulation techniques for the diagnosis and the treatment of neurodegenerative diseases
Additioanl information
* This call for proposals is an open call for proposals
* Initial duration of the action: 3 years
* Eligibility:
– Be research groups working in universities (or other higher education institutions), non-university public or private research institutes, hospitals and other health and social care settings, as well as commercial companies, in particular small and medium-size enterprises (SMEs);
– Collaborations with companies from outside the traditional medical sector (e.g. computing, artificial intelligence) are welcome;
– The consortia must involve a minimum of three and a maximum of six regular partners, including the coordinator;
– The consortia must be from at least three different countries participating in this call;
– The consortia must have no more than two regular partners from the same country
* Amount of the grant: depending on the funding organisation
25 August 2021
